The article; Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks was accepted 31 May 2023, date of publication 6 June 2023.
Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer that affects younger individuals and African Americans disproportionately. EMOL Health took part with researchers studying TNBC’s pathways and found that targeting certain genes (STAT3, GLI, and NF-κB) and using combinations of drugs could potentially prevent TNBC from returning.
For the Article PDF, click here.